ReviewBiomedicines2022

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma.

Alessandro Vatrella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.